Trials / Unknown
UnknownNCT03819075
Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis
An Evaluation Of Effectiveness Of A Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Luis Monteiro · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A laser treatment for periimplantitis using two different wavelengths (Er:YAG and Nd:YAG) will be compared to standard treatment in a randomized clinical trial.
Detailed description
The general aim of this study is to evaluate the clinical outcome of the treatment of peri-implantitis using a combination of a Er:YAG and Nd:YAG laser protocol or using a conventional mechanical treatment in patients with a diagnosis of peri-implantitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lightwalker Laser (Fotona) | For the laser group we will use a Lightwalker Laser (Fotona) with a Er:YAG 2940 nm and Nd:YAG 1064 nm wavelengths units. The laser protocol will follow the instructions of the manufacturer (TwinLight protocol) and consists of degranulation of necrotic soft tissue and bone, implant surface disinfection and creating spot bleeding in bone with Er:YAG and deep disinfection and biomodulation with Nd:YAG. |
| OTHER | standard | Granulation tissue elimination, mechanical instrumentation of the implant surface and curettage of intraosseous or supracrestally bone defects will be accomplished using plastic curets, under irrigation with sterile saline solution. Cotton pellets soaked in sterile saline solution will be use to clean debris and remains of removed tissue. |
Timeline
- Start date
- 2018-03-03
- Primary completion
- 2023-12-01
- Completion
- 2024-05-01
- First posted
- 2019-01-28
- Last updated
- 2023-09-01
Locations
1 site across 1 country: Portugal
Source: ClinicalTrials.gov record NCT03819075. Inclusion in this directory is not an endorsement.